Literature DB >> 28069136

The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.

K Moriwaki1, F K-M Chan2.   

Abstract

Receptor interacting protein kinase 3 (RIPK3) is an essential serine/threonine kinase for necroptosis, a type of regulated necrosis. A variety of stimuli can cause RIPK3 activation through phosphorylation. Activated RIPK3 in turn phosphorylates and activates the downstream necroptosis executioner mixed lineage kinase domain-like (MLKL). Necroptosis is a highly inflammatory type of cell death because of the release of intracellular immunogenic contents from disrupted plasma membrane. Indeed, RIPK3-deficient mice exhibited reduced inflammation in many inflammatory disease models. These results have been interpreted as evidence that necroptosis is a key driver for RIPK3-induced inflammation. Interestingly, recent studies show that RIPK3 also regulates NF-κB, inflammasome activation, and kinase-independent apoptosis. These studies also reveal that these nonnecroptotic functions contribute significantly to disease pathogenesis. In this review, we summarize our current understanding of necroptotic and nonnecroptotic functions of RIPK3 and discuss how these effects contribute to RIPK3-mediated inflammation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MLKL; NF-κB; RIPK1; RIPK3; TNF; apoptosis; caspase 8; inflammasome; inflammation; necroptosis

Mesh:

Substances:

Year:  2016        PMID: 28069136      PMCID: PMC5791152          DOI: 10.1016/bs.ircmb.2016.08.007

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  118 in total

1.  cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis.

Authors:  Diana Panayotova-Dimitrova; Maria Feoktistova; Michaela Ploesser; Beate Kellert; Mike Hupe; Sebastian Horn; Roman Makarov; Federico Jensen; Stefan Porubsky; Astrid Schmieder; Ana Claudia Zenclussen; Alexander Marx; Andreas Kerstan; Peter Geserick; You-Wen He; Martin Leverkus
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

2.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

3.  RIP3, a novel apoptosis-inducing kinase.

Authors:  X Sun; J Lee; T Navas; D T Baldwin; T A Stewart; V M Dixit
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

4.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

5.  The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.

Authors:  Florent Dufour; A Marie-Josée Sasseville; Stéphane Chabaud; Bernard Massie; Richard M Siegel; Yves Langelier
Journal:  Apoptosis       Date:  2011-03       Impact factor: 4.677

6.  Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.

Authors:  Marta B Afonso; Pedro M Rodrigues; Tânia Carvalho; Marta Caridade; Paula Borralho; Helena Cortez-Pinto; Rui E Castro; Cecília M P Rodrigues
Journal:  Clin Sci (Lond)       Date:  2015-06-15       Impact factor: 6.124

7.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

8.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

9.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

10.  Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways.

Authors:  Vincent F-S Shih; Jeremy Davis-Turak; Monica Macal; Jenny Q Huang; Julia Ponomarenko; Jeffrey D Kearns; Tony Yu; Riku Fagerlund; Masataka Asagiri; Elina I Zuniga; Alexander Hoffmann
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606

View more
  25 in total

1.  Lysis of human neutrophils by community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Mallary C Greenlee-Wacker; Silvie Kremserová; William M Nauseef
Journal:  Blood       Date:  2017-05-04       Impact factor: 22.113

2.  PPARα exacerbates necroptosis, leading to increased mortality in postinfluenza bacterial superinfection.

Authors:  Vincent C Tam; Rosa Suen; Piper M Treuting; Aaron Armando; Ronald Lucarelli; Norma Gorrochotegui-Escalante; Alan H Diercks; Oswald Quehenberger; Edward A Dennis; Alan Aderem; Elizabeth S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-24       Impact factor: 11.205

3.  SBP-0636457, a Novel Smac Mimetic, Cooperates with Doxorubicin to Induce Necroptosis in Breast Cancer Cells during Apoptosis Blockage.

Authors:  Rui Yu; Lei Wang; Xiaochun Ji; Chenxiao Mao
Journal:  J Oncol       Date:  2022-07-11       Impact factor: 4.501

4.  Lung-derived HMGB1 is detrimental for vascular remodeling of metabolically imbalanced arterial macrophages.

Authors:  Ludovic Boytard; Tarik Hadi; Michele Silvestro; Hengdong Qu; Andrew Kumpfbeck; Rayan Sleiman; Kissinger Hyppolite Fils; Dornazsadat Alebrahim; Francesco Boccalatte; Matthias Kugler; Annanina Corsica; Bruce E Gelb; Glenn Jacobowitz; George Miller; Chiara Bellini; Jessica Oakes; Jean-Sébastien Silvestre; Lior Zangi; Bhama Ramkhelawon
Journal:  Nat Commun       Date:  2020-08-27       Impact factor: 14.919

5.  A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation.

Authors:  Zhijun Liu; Himani Nailwal; Jonah Rector; Masmudur M Rahman; Richard Sam; Grant McFadden; Francis Ka-Ming Chan
Journal:  Immunity       Date:  2021-01-13       Impact factor: 31.745

6.  Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines.

Authors:  Annkathrin Koch; Birte Jeiler; Jens Roedig; Sjoerd J L van Wijk; Nadezda Dolgikh; Simone Fulda
Journal:  Neoplasia       Date:  2021-05-07       Impact factor: 5.715

7.  Bone Marrow-Derived RIPK3 Mediates Kidney Inflammation in Acute Kidney Injury.

Authors:  Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Miguel Fontecha-Barriuso; Nerea Mendez-Barbero; Maria Laura Saiz; Ana M Lopez-Diaz; Maria D Sanchez-Niño; Susana Carrasco; Pablo Cannata-Ortiz; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  J Am Soc Nephrol       Date:  2022-01-19       Impact factor: 10.121

8.  The enhanced susceptibility of ADAM-17 hypomorphic mice to DSS-induced colitis is not ameliorated by loss of RIPK3, revealing an unexpected function of ADAM-17 in necroptosis.

Authors:  Johaiber Fuchslocher Chico; Maren Falk-Paulsen; Anne Luzius; Carina Saggau; Barbara Ruder; Julia Bolik; Dirk Schmidt-Arras; Andreas Linkermann; Christoph Becker; Philip Rosenstiel; Stefan Rose-John; Dieter Adam
Journal:  Oncotarget       Date:  2018-02-05

9.  Combined Knockout of RIPK3 and MLKL Reveals Unexpected Outcome in Tissue Injury and Inflammation.

Authors:  Caroline Moerke; Florian Bleibaum; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Front Cell Dev Biol       Date:  2019-02-20

Review 10.  Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists.

Authors:  G Morris; A J Walker; M Berk; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2017-10-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.